People with Diabetes have a choice.

Help them live a healthy life.  

“Diabetes Self-Management Education is an interactive, collaborative, ongoing process involving the person with diabetes and the educator(s),” according to the American Diabetes Association.

This process includes:

• assessment of the individual’s specific education needs

• identification of the individual’s specific diabetes self-management goals

• education and behavioral intervention directed toward helping the individual achieve identified self-management goals

• evaluation of the individual’s attainment of identified self-management goals

To aid in diabetes education and treatment, BioSignia, Inc. has developed a diabetes risk management tool that is both interactive and personalized, enabling individuals to successfully manage their disease. The individual’s unique likelihood of developing the complications associated with diabetes is calculated by correlating the latest scientific findings on major risk factors such as blood pressure, HbA1C and cholesterol with the onset of cardiovascular disease, retinopathy, renal disease, and nervous system damage. The technology illustrates the importance of complying with physician treatment plans and includes what-if analysis to determine appropriate goals to achieve acceptable risk levels.

BioSignia’s Diabetes Risk Management Technology was created with the assistance of Duke University Medical Center’s department of endocrinology, headed by Mark Feinglos, M.D., C.M., and was presented at the American Diabetes Association 61st annual scientific session. Dr. Feinglos had this to say about the technology and its usefulness to both patient and educator, “The system provides a very powerful tool for individualized patient counseling and education and the graphic display provides an easy to understand picture to the patient regarding their risk of disease complications and instantaneous feedback on how health improvements can reduce these risks.”

Recently, Health and Human Services Secretary Tommy Thompson announced new guidelines aimed at identifying people likely to develop type 2 diabetes, the most common form of diabetes. In addition, the ADA issued this position statement. “Pre-diabetes is a clearer way of explaining what it means to have higher than normal blood glucose levels. It means you are likely to develop diabetes and may already be experiencing the adverse health effects of this serious condition. People with pre-diabetes have a 1.5-fold risk of cardiovascular disease compared to people with normal blood glucose. We now know that people with pre-diabetes can delay or prevent the onset of type 2 diabetes through lifestyle changes.”

To address this need for early identification and intervention, BioSignia, Inc., a healthcare bioinformatics company that specializes in understanding the epidemiology of slowly developing multifactor diseases, has developed a technology that forecasts disease risk. This technology accurately identifies the level of risk in individuals for the onset of type 2 diabetes, coronary heart disease and stroke, and illustrates the proportion of that risk that is modifiable through clinical and lifestyle interventions.

FOR MORE INFORMATION, CONTACT US AT:

(919) 933-2021 • (888) 324-6627

info@biosignia.com

Visit our website at www.biosignia.com